Magnetic Resonance Silent Activatable Probe with Massive Signal Amplification for Rapid Detection of Inflammation-Associated Fibrogenesis

Abstract Biomarker-specific molecular imaging is vital in precision medicine. However, a fundamental challenge of most molecular imaging methods is the difficulty of distinguishing specific molecular signal from nonspecific signal arising from the distribution of the molecular probe. This is even more pronounced in metabolically active organs such as the kidney and liver where the probe may concentrate prior to elimination. As a result, almost all molecular imaging relies on delayed imaging to achieve specificity, but this constrains clinical throughput and impedes rapid assessment of the diseased organ. Here, we report a magnetic resonance (MR) probe, Fe(II)-IAFP2, which combines 3 drivers of relaxivity enhancement to decouple disease specificity from probe distribution. Fe(II)-IAFP2 is MR-silent in its Fe(II) state, producing negligible MR signal even at high concentrations. In inflammatory, fibrogenic microenvironments common to many diseases, rapid oxidation to Fe(III) activates MR enhancement, while reversible aldehyde-mediated binding to remodeled extracellular matrix further amplifies relaxivity and promotes retention at the site of tissue injury. This dual activation–retention mechanism enables robust signal generation within minutes of administration. In mouse models of renal and liver fibrogenesis, Fe(II)-IAFP2 generated disease-associated MR contrast within minutes after intravenous administration. Together, this work demonstrates an effective strategy for rapid, activity-based molecular MR imaging through the combination of pathological activation and complementary tissue retention.

Authors

Institutions

Publication Details

Journal
Journal of the American Chemical Society
Published
2026-11-12
DOI
https://doi.org/10.1021/jacs.6c16146
Primary Topic
Lanthanide and Transition Metal Complexes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Magnetic Resonance Silent Activatable Probe with Massive Signal Amplification for Rapid Detection of Inflammation-Associated Fibrogenesis

Tingting Zha, Ivy A. Rosales, Mariane Le Fur, Yuanlin Zhang et al.
Journal of the American Chemical Society
Lanthanide and Transition Metal Complexes
article

Magnetic Resonance Silent Activatable Probe with Massive Signal Amplification for Rapid Detection of Inflammation-Associated Fibrogenesis

Tingting Zha, Ivy A. Rosales, Mariane Le Fur, Yuanlin Zhang, Peter D. Caravan, Hua Ma, Eric M. Gale, Nicholas Joseph Rotile, Jinbin Pan, Fumitaro Masaki, Iris Yuwen Zhou, İlknur Ay, Veronica Clavijo Jordan, Chloe Brasket, Dongjun Li, Lydia Pollard, Jessica Klein, Stuti Shroff
article en

Abstract

Abstract Biomarker-specific molecular imaging is vital in precision medicine. However, a fundamental challenge of most molecular imaging methods is the difficulty of distinguishing specific molecular signal from nonspecific signal arising from the distribution of the molecular probe. This is even more pronounced in metabolically active organs such as the kidney and liver where the probe may concentrate prior to elimination. As a result, almost all molecular imaging relies on delayed imaging to achieve specificity, but this constrains clinical throughput and impedes rapid assessment of the diseased organ. Here, we report a magnetic resonance (MR) probe, Fe(II)-IAFP2, which combines 3 drivers of relaxivity enhancement to decouple disease specificity from probe distribution. Fe(II)-IAFP2 is MR-silent in its Fe(II) state, producing negligible MR signal even at high concentrations. In inflammatory, fibrogenic microenvironments common to many diseases, rapid oxidation to Fe(III) activates MR enhancement, while reversible aldehyde-mediated binding to remodeled extracellular matrix further amplifies relaxivity and promotes retention at the site of tissue injury. This dual activation–retention mechanism enables robust signal generation within minutes of administration. In mouse models of renal and liver fibrogenesis, Fe(II)-IAFP2 generated disease-associated MR contrast within minutes after intravenous administration. Together, this work demonstrates an effective strategy for rapid, activity-based molecular MR imaging through the combination of pathological activation and complementary tissue retention.

Journal of the American Chemical Society
Canon (Japan) (JP), Harvard University (US), Massachusetts General Hospital (US), Canon (United States) (US), Athinoula A. Martinos Center for Biomedical Imaging (US)
Canon Medical Systems USA, NIH Office of the Director, National Institute of Diabetes and Digestive and Kidney Diseases
Good health and well-being
Lanthanide and Transition Metal Complexes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon